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Abstract 
Background: The nature and degree of cognitive impairments in schizoaffective 
disorder is not well established. The aim of this meta-analysis was to characterise 
cognitive functioning in schizoaffective disorder and compare it with cognition in 
schizophrenia and bipolar disorder. Schizoaffective disorder was considered both as 
a single category and as its two diagnostic subtypes, bipolar and depressive disorder. 
Methods: Following a thorough literature search (468 records identified), we 
included 31 studies with a total of 1685 participants with schizoaffective disorder, 
3357 with schizophrenia and 1095 with bipolar disorder. Meta-analyses were 
conducted for seven cognitive variables comparing performance between 
participants with schizoaffective disorder and schizophrenia, and between 
schizoaffective disorder and bipolar disorder. 
Results: Participants with schizoaffective disorder performed worse than those with 
bipolar disorder (g=-0.30) and better than those with schizophrenia (g=0.17). Meta-
analyses of the subtypes of schizoaffective disorder showed cognitive impairments in 
participants with the depressive subtype are closer in severity to those seen in 
participants with schizophrenia (g=0.08), whereas those with the bipolar subtype 
were more impaired than those with bipolar disorder (g=-0.23) and less impaired 
than those with schizophrenia (g=0.29). Participants with the depressive subtype had 
worse performance than those with the bipolar subtype but this was not significant 
(g=0.25, p=0.05). 
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Conclusion: Cognitive impairments increase in severity from bipolar disorder to 
schizoaffective disorder to schizophrenia. Differences between the subtypes of 
schizoaffective disorder suggest combining the subtypes of schizoaffective disorder 
may obscure a study’s results and hamper efforts to understand the relationship 
between this disorder and schizophrenia or bipolar disorder. 
Key words: Schizoaffective disorder / subtypes / review / memory / attention 
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Introduction 1 
Schizophrenia and bipolar disorder have traditionally been considered to be discrete 2 
categories in diagnostic classification. In contrast studies examining clinical features, 3 
genetic risk and neuroimaging data suggest there are overlaps between these 4 
disorders (Craddock & Owen, 2010; Ivleva et al., 2013; Keshavan et al., 2011; 5 
Ruderfer et al., 2018). The intermediate diagnosis, “schizoaffective disorder” was 6 
introduced due to the observation that some patients exhibit symptoms of 7 
schizophrenia and mood disturbance (Jäger, Haack, Becker, & Frasch, 2011). 8 
Schizoaffective disorder can be separated into two distinct subtypes: depressive and 9 
bipolar. However, the relationship between schizoaffective disorder, including the 10 
two subtypes, and schizophrenia or bipolar disorder remains unclear. Investigating 11 
the nature and degree of the cognitive impairments associated with schizoaffective 12 
disorder may further elucidate the relationship between these psychotic disorders.  13 
It is well established that a broad range of cognitive abilities are impaired in a large 14 
number of patients with schizophrenia (Fatouros-Bergman, Cervenka, Flyckt, Edman, 15 
& Farde, 2014; Fioravanti, Carlone, Vitale, Cinti, & Clare, 2005; Heinrichs & Zakzanis, 16 
1998). Cognitive impairments are also present in patients with schizoaffective 17 
disorder and bipolar disorder, albeit milder than in schizophrenia (Emre Bora, Yucel, 18 
& Pantelis, 2009; Krabbendam, Arts, van Os, & Aleman, 2005; Stefanopoulou et al., 19 
2009). These differences are not consistent across cognitive domains. Bora et al. 20 
(Emre Bora et al., 2009) reported differences between participants with 21 
schizophrenia and affective psychosis (schizoaffective disorder and bipolar disorder) 22 
in verbal memory, IQ, verbal working memory and executive function but no 23 
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differences in visual memory, attention or spatial working memory tests in their 24 
meta-analysis of twelve cognitive abilities.  25 
Meta-analyses comparing cognitive performance between schizophrenia and 26 
affective psychosis have detected heterogeneity of effect sizes between studies 27 
(Emre Bora et al., 2009; Krabbendam et al., 2005). More recent reviews have 28 
attempted to reduce this heterogeneity by examining specific diagnoses and 29 
subgroups (E. Bora, Yucel, Fornito, Berk, & Pantelis, 2008; Kuswanto et al., 2016; K. 30 
Lewandowski, Cohen, & Öngur, 2011; Madre et al., 2016). These reviews have 31 
concluded that participants with schizophrenia, particularly those with prominent 32 
negative symptoms, exhibit the most severe cognitive deficits (E. Bora et al., 2008; 33 
Kuswanto et al., 2016; K. Lewandowski et al., 2011). Participants with bipolar 34 
disorder and no history of psychosis have the least severe cognitive deficits (E. Bora 35 
et al., 2008; Kuswanto et al., 2016; K. Lewandowski et al., 2011). There is also 36 
evidence that participants with bipolar disorder – type II have better cognitive 37 
functioning than participants with bipolar disorder – type I (Simonsen et al., 2008; 38 
Torrent et al., 2006). The cognitive performance of participants with either bipolar 39 
disorder and psychosis or schizoaffective disorder appears to be intermediate 40 
between bipolar disorder without psychosis and schizophrenia (E. Bora et al., 2008; 41 
Kuswanto et al., 2016). Bora et al. (E. Bora et al., 2008) concluded that participants 42 
who were experiencing psychotic symptoms during assessment exhibited similar 43 
cognitive impairments irrespective of diagnosis. However, Madre et al. (Madre et al., 44 
2016) suggest that the degree of cognitive impairments in schizoaffective disorder is 45 
closer to that of schizophrenia than bipolar disorder and schizoaffective disorder 46 
may represent a subtype of schizophrenia.  47 
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To date, reviews examining the subtypes of disorders have conducted narrative 48 
synthesis of the studies but there have been no attempts to aggregate this existing 49 
data into a meta-analysis.  To our knowledge, there have been no meta-analyses 50 
comparing cognitive function between schizoaffective disorder and bipolar disorder 51 
or comparing the subtypes of schizoaffective disorder. We feel this is an important 52 
consideration as there is evidence to suggest that the depressive subtype of 53 
schizoaffective disorder may be associated with cognitive impairment closer to that 54 
of schizophrenia, whilst those with the bipolar subtype are less impaired (Hill et al., 55 
2013; Lynham et al., 2018). This suggests that the proportion of each subtype 56 
included in schizoaffective disorder samples could influence study results.  57 
Our aim was to conduct meta-analyses to examine cognitive performance across the 58 
bipolar-schizophrenia diagnostic spectrum. Studies that compared the subtypes of 59 
schizoaffective disorder to schizophrenia and bipolar disorder were also reviewed. 60 
Our hypothesis was that cognitive impairments in schizoaffective disorder would be 61 
intermediate between those observed in bipolar disorder and schizophrenia. We 62 
further hypothesised that the depressive subtype of schizoaffective disorder would 63 
be associated with more severe cognitive impairments similar to schizophrenia, 64 
whilst impairments in the bipolar subtype would be less severe than those of 65 
schizophrenia but more impaired than those of bipolar disorder. 66 
Methods 67 
 68 
Study selection 69 
This review was conducted following guidelines from the Preferred Reporting Items 70 
for Systematic Reviews and Meta-Analyses (PRISMA) (Moher, Liberati, Tetzlaff, & 71 
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Altman, 2009). We conducted searches for articles published between January 1980 72 
and February 2019 in PubMed, PsycINFO, Web of Science and EMBASE. The 73 
keywords, “schizophrenia”, “schizoaffective” and “bipolar” combined with 74 
“cogniti*”, “neurocogniti*” and “neuropsycholog*” were used. The latter terms 75 
were also replaced with keywords that describe cognitive domains (memory, 76 
attention and executive function). The bibliographies of published articles were also 77 
reviewed. 78 
The inclusion criteria included all full text publications that: 79 
1. Directly compared participants with schizoaffective disorder to those with 80 
schizophrenia, bipolar disorder or both disorders but did not combine 81 
different diagnoses into a single group (e.g. affective psychosis).  82 
2. Included adults (aged 16 years or over) diagnosed using versions of DSM, ICD 83 
or Research Diagnostic Criteria (RDC).  84 
3. Included published assessments of cognition for the following domains: 85 
executive function, speed of processing, working memory, immediate verbal 86 
learning, immediate visuospatial learning or verbal fluency. 87 
4. Reported independent data. When studies with overlapping samples were 88 
identified and both met inclusion criteria, the study with the largest sample 89 
was selected.  90 
Recorded variables were: 91 
1. Name of the first author and year of publication 92 
2. Number of participants in each diagnostic group and proportion of subtypes 93 
for schizoaffective disorder 94 
3. Sample characteristics (inpatients or outpatients, diagnostic criteria used) 95 
and status of patients (acute, stabilised, in remission), where defined 96 
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4. Cognitive test or battery results.  97 
Authors were contacted for missing data. 98 
Neuropsychological variables 99 
We set an a priori primary study outcome of a general cognitive performance 100 
measure that allowed comparisons across studies. We calculated this composite 101 
cognition effect size and its 95% confidence intervals using the mean and standard 102 
error of the effect sizes of the individual tests or domains. This included all tests 103 
reported in each paper in order to maximise the number of studies included. 104 
Composite scores were only calculated for studies with three or more tests available, 105 
as has been done in previous studies (Lencz et al., 2013).  106 
In addition to general cognitive function, we selected domains based on the 107 
Measurement in Assessment and Treatment Research to Improve Cognition in 108 
Schizophrenia (MATRICS) initiative (Nuechterlein et al., 2004), as we have done in 109 
our previous work (Niarchou et al., 2013). Tasks were assigned to domains based on 110 
the MATRICS and previous reviews (Emre Bora et al., 2009; Kuswanto et al., 2016). 111 
The domains included were verbal learning, visuospatial learning, executive function, 112 
speed of processing, verbal fluency and working memory. The tasks included in each 113 
domain can be found in supplementary table S1. If a study included more than one 114 
task for a single domain, the effect sizes were averaged to create a single domain 115 
score. For tasks with multiple outcome measures, the most common outcome 116 
measure used across the studies was included. 117 
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Statistical analyses 118 
Meta-analyses were conducted to compare general cognitive performance and 119 
domain-specific cognition between the following diagnoses: 120 
1. Schizoaffective disorder and schizophrenia (N=22) 121 
2. Schizoaffective disorder and bipolar disorder (N=10) 122 
3. Schizoaffective disorder and bipolar disorder with psychosis (N=4) 123 
4. Schizoaffective disorder and bipolar disorder without psychosis (N=3) 124 
5. Schizoaffective disorder – depressive type and schizophrenia (N=4) 125 
6. Schizoaffective disorder – depressive type and bipolar disorder (N=3) 126 
7. Schizoaffective disorder – bipolar type and schizophrenia (N=3) 127 
8. Schizoaffective disorder – bipolar type and bipolar disorder (N=4) 128 
9. Schizoaffective disorder – bipolar type and schizoaffective disorder – 129 
depressive type (N=2) 130 
Effect sizes were calculated for each pair of comparisons using the formulas 131 
described by Rosnow and Rosenthal (Rosnow & Rosenthal, 1996) and Rosnow, 132 
Rosenthal and Rubin (Rosnow, Rosenthal, & Rubin, 2000). We used Hedge’s 133 
correction for bias due to uneven group sizes to calculate the pooled standard 134 
deviation (Hedges & Olkin, 1985). All effect sizes were calculated such that a positive 135 
effect size would indicate that the schizoaffective disorder group had performed 136 
better than the comparison group.  137 
Meta-analyses were conducted using the package, “meta” in R v3.3.1. A random 138 
effects model was used (DerSimonian-Laird estimate (DerSimonian & Laird, 1986)). 139 
Effect sizes were weighted using the inverse variance method. Homogeneity of the 140 
 10  
effect sizes was tested using the Q-test. Funnel plots and Egger’s test were used to 141 
assess reporting bias.  142 
Meta-regression analyses were conducted to estimate the moderating effects of age, 143 
sex, years in education, age of onset, illness duration, current antipsychotic 144 
medication use, current psychotic symptoms, current depressive symptoms, current 145 
negative symptoms and current manic symptoms on the composite cognition 146 
findings. Meta-regression analyses were performed with a random effects model 147 
using the restricted-information maximum likelihood method in R using the package, 148 
“metafor”.   149 
A sensitivity analysis was conducted by repeating the meta-analysis comparing 150 
bipolar disorder and schizoaffective disorder excluding papers that included bipolar 151 
disorder - type II in their sample. 152 
153 
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Results 154 
 155 
Retrieved studies 156 
A total of 468 records were identified from the initial searches and the abstracts 157 
screened for inclusion. Initially, 419 studies were excluded as either duplicates or not 158 
meeting inclusion criteria. A further 18 articles were excluded after examination of 159 
the full texts, mainly because these studies had combined diagnostic groups and 160 
thus we were unable to calculate separate effect sizes. One study was excluded 161 
because summary statistics or effect sizes were not available. This resulted in 31 162 
studies being included in the meta-analysis. In total, there were 1685 participants 163 
with schizoaffective disorder, 3357 participants with schizophrenia and 1095 164 
participants with bipolar disorder. Figure 1 shows the PRISMA flowchart illustrating 165 
the process of filtering potential studies. Full details of the final studies included can 166 
be found in supplementary table S2. 167 
Schizophrenia and schizoaffective disorder 168 
Composite cognition effect sizes were calculated for 22 studies comparing 169 
schizoaffective disorder (n=1166) and schizophrenia (n=2851). Participants with 170 
schizoaffective disorder performed better than participants with schizophrenia 171 
based on composite cognition scores (g=0.17, p<0.0001, see Figure 2). Effect size 172 
distributions were homogeneous (Τ2=0 .002; Q=22.64, p=0.36) and there was no 173 
evidence of publication bias (Egger: bias = -0.23). Meta-regression analyses were 174 
conducted to investigate the influence of nine variables: age, sex, years in education, 175 
age of onset, duration of illness, antipsychotic use, psychotic, depressive and 176 
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negative symptoms. Meta-regression analyses were not significant for any of the 177 
variables examined (see supplementary table S3). 178 
In analyses examining individual cognitive domains, the schizoaffective group 179 
outperformed the schizophrenia group in verbal learning (g=0.24), speed of 180 
processing (g=0.18), visuospatial learning (g=0.20), verbal fluency (g=0.14) and 181 
working memory (g=0.09), although there was evidence of heterogeneity in the 182 
domains of verbal learning, executive function and speed of processing (see 183 
supplementary table S4).  184 
The meta-analyses were repeated for the separate subtypes of schizoaffective 185 
disorder: schizoaffective bipolar type and schizoaffective depressive type (see Table 186 
1 for results). There was no significant difference between participants with 187 
schizophrenia and participants with schizoaffective disorder – depressive type 188 
(g=0.08, p=0.35). Participants with schizoaffective disorder – bipolar type 189 
outperformed participants with schizophrenia (g=0.29, p=0.0003). The results of the 190 
Q-test and Egger’s test indicated that there was little evidence of heterogeneity or 191 
publication bias, but these tests have low power when there is only a small number 192 
of studies included. 193 
Bipolar disorder and schizoaffective disorder 194 
Composite cognition effect sizes were calculated for 10 studies comparing 195 
schizoaffective disorder (n=732) and bipolar disorder (n=946). Participants with 196 
schizoaffective disorder performed worse than participants with bipolar disorder 197 
(g=-0.30, p<0.0001, see Figure 3). Effect size distributions were homogeneous 198 
(Τ2<0.0001; Q=7.75, p=0.56) and there was no evidence of publication bias (Egger: 199 
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bias = 0.99). These results did not change when the analysis was repeated including 200 
participants with bipolar disorder – type I only (g=-0.30, p<0.0001). Participants with 201 
schizoaffective disorder performed worse than participants with bipolar disorder and 202 
psychosis (g=-0.39, p=0.0002), and participants with bipolar disorder without a 203 
history of psychosis (g=-0.47, p=0.001). Meta-regression analyses were conducted to 204 
investigate the influence of eight variables: age, sex, duration of illness, antipsychotic 205 
use, psychotic, depressive, negative and manic symptoms. There was insufficient 206 
data to examine the influence of age of onset and years in education for studies 207 
comparing bipolar disorder and schizoaffective disorder. Meta-regression analyses 208 
were not significant for any of the variables examined (see supplementary table S3). 209 
In analyses examining individual cognitive domains, performance in the 210 
schizoaffective group was worse than bipolar disorder in verbal learning (g=-0.42), 211 
executive function (g=-0.36), speed of processing (g=-0.35), verbal fluency (g=-0.32) 212 
and working memory (g=-0.30, see supplementary table S4). Data comparing 213 
visuospatial learning between bipolar disorder and schizoaffective disorder were not 214 
available. There was evidence of heterogeneity in the effect sizes for speed of 215 
processing (Q=13.45, p=0.04) and verbal learning (Q=13.41, p=0.02). 216 
The meta-analyses were repeated for the separate subtypes of schizoaffective 217 
disorder: schizoaffective bipolar type and schizoaffective depressive type (see Table 218 
1 for results). The schizoaffective bipolar group had lower overall cognitive scores 219 
than bipolar disorder (g=-0.23, p=0.003). The schizoaffective depressive group were 220 
more impaired than those with bipolar disorder (g=-0.47, p<0.0001). The results of 221 
the Q-test and Egger’s test indicated that there was little evidence of heterogeneity 222 
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or publication bias, but these tests have low power when there is only a small 223 
number of studies included. 224 
Subtypes of schizoaffective disorder 225 
Only two studies reported separate cognitive data for both subtypes of 226 
schizoaffective disorder, bipolar (N=186) and depressive (N=167). Participants with 227 
the depressive subtype of schizoaffective disorder had worse performance than 228 
those with the bipolar subtype but this difference was not significant (g=0.25, 229 
p=0.05). Effect size distributions were homogeneous (Τ2=0.008; Q=1.31, p=0.25). 230 
Egger’s bias cannot be calculated for two studies. 231 
Discussion 232 
The aim of this meta-analysis was to compare cognitive outcomes of schizoaffective 233 
disorder with schizophrenia and bipolar disorder. This is the first meta-analysis to 234 
compare cognitive performance of participants with schizoaffective disorder and 235 
bipolar disorder. It is also the first review that has examined whether the subtypes of 236 
schizoaffective disorder differ in cognitive outcomes compared to schizophrenia and 237 
bipolar disorder. Cognitive performance of participants with schizoaffective disorder 238 
was intermediate between those with bipolar disorder and schizophrenia. Meta-239 
analyses of the subtypes of schizoaffective disorder indicated that participants with 240 
the depressive subtype had cognitive impairments closer in severity to those seen in 241 
participants with schizophrenia, whereas those with the bipolar subtype were more 242 
impaired than participants with bipolar disorder and less impaired than those with 243 
schizophrenia (see Figure 4). Participants with the depressive subtype had worse 244 
cognitive performance than those with the bipolar subtype but this was not 245 
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significant and only two studies had reported separate cognitive data for both 246 
subtypes. 247 
Schizoaffective disorder and bipolar disorder 248 
The schizoaffective disorder group exhibited worse performance across all cognitive 249 
domains compared to the bipolar disorder group. This supports the conclusions of a 250 
review by Madre et al. (Madre et al., 2016) who suggested that cognitive 251 
impairments are more severe in schizoaffective disorder than in bipolar disorder. 252 
Other reviews have concluded that bipolar disorder and psychosis is associated with 253 
similar cognitive impairments to those seen in schizoaffective disorder (E. Bora et al., 254 
2008), whilst participants with bipolar disorder and no history of psychosis have less 255 
severe deficits (E. Bora et al., 2008; Kuswanto et al., 2016; K. Lewandowski et al., 256 
2011). We found evidence that both subtypes of bipolar disorder (with and without 257 
history of psychosis) had less severe impairments than schizoaffective disorder, 258 
although a larger magnitude of effect size was found between schizoaffective 259 
disorder and bipolar disorder without psychosis than the difference between 260 
schizoaffective disorder and bipolar disorder with psychosis. Our results expand on 261 
previous reviews by showing that mania within schizoaffective disorder is associated 262 
with less impaired cognition, compared to participants with schizoaffective disorder 263 
– depressive type and schizophrenia. Taken together, these results suggest that 264 
there is not a simple dichotomy in cognitive function between those with a history of 265 
psychosis and those without. The reasons why participants with a diagnosis of a 266 
manic disorder are less cognitively impaired than participants with schizophrenia are 267 
unclear but could include differences in illness course (episodic or chronic), symptom 268 
profiles, age of onset, medication or underlying psychopathology. In their meta-269 
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analysis comparing cognition between schizophrenia and bipolar disorder, Bora et al. 270 
(Emre Bora et al., 2009) reported that variability in the magnitude of the effect sizes 271 
between studies was driven by the percentage of males, severity of negative 272 
symptoms and age of onset of the schizophrenia samples included, and these factors 273 
may also impact performance in schizoaffective disorder. There is some evidence 274 
that current mood symptoms, particularly depressive symptoms, are associated with 275 
greater impairments in executive function and verbal fluency (Chaves et al., 2011; 276 
Frangou, Donaldson, Hadjulis, Landau, & Goldstein, 2005). However, we did not find 277 
any moderating effects of current depressive, psychotic, manic or negative 278 
symptoms in these analyses. 279 
Bipolar disorder – type I has been shown to be associated with more widespread 280 
cognitive impairments than type II (E. Bora, Yücel, Pantelis, & Berk, 2011). The 281 
results of a sensitivity analysis including type I only was comparable to the meta-282 
analysis including both subtypes. However, it was not possible to compare bipolar 283 
disorder – type II and schizoaffective disorder, as only one study reported separate 284 
data for type II. 285 
Schizoaffective disorder and schizophrenia 286 
Participants with schizoaffective disorder were less cognitively impaired than 287 
participants with schizophrenia. This is consistent with the findings of an earlier 288 
meta-analysis (Emre Bora et al., 2009). The effect size reported in the current study 289 
(g=0.17) fell within the range of effect sizes reported by the earlier meta-analysis 290 
(d=0.08-0.32). The difference between schizoaffective disorder and schizophrenia 291 
was smaller than the effect size of the schizoaffective disorder and bipolar disorder 292 
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analysis (g=-0.30). This is consistent with the conclusions drawn in the review by 293 
Madre et al. (Madre et al., 2016), which suggested that the degree of cognitive 294 
impairments in schizoaffective disorder is closer to that of schizophrenia than bipolar 295 
disorder. 296 
There were inconsistencies between the results of the individual studies, with 297 
approximately half of the studies reporting greater impairment in the schizophrenia 298 
group than the schizoaffective disorder group and the remaining studies reporting 299 
no differences. There are a number of factors that may account for these 300 
inconsistent findings, including differences in cognitive assessments, the recruitment 301 
of acutely unwell versus euthymic patients, and the inclusion of subtypes of 302 
schizophrenia and schizoaffective disorder. Studies included in this meta-analysis 303 
have reported that the presence of negative symptoms or the inclusion of 304 
participants with non-paranoid subtypes of schizophrenia are associated with more 305 
severe impairments (Bornstein et al., 1990; Goldstein, Shemansky, & Allen, 2005; 306 
Savage, Jackson, & Sourathathone, 2003; Torniainen et al., 2012). In addition, we 307 
found evidence that the subtypes of schizoaffective disorder may be associated with 308 
differing levels of cognitive impairment (Hill et al., 2013; Lynham et al., 2018) 309 
(discussed further in the next section). However, we did not find any moderating 310 
effects of age, sex, age of onset, duration of illness, years in education, psychotic, 311 
depressive or negative symptoms. In conclusion, the proportion of participants with 312 
each subtype of schizoaffective disorder or schizophrenia may influence the effect 313 
sizes in comparisons of cognitive function between schizophrenia and schizoaffective 314 
disorder. 315 
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Cognition across the three disorders 316 
It has been hypothesised that schizoaffective disorder may represent the midpoint in 317 
a bipolar-schizophrenia diagnostic spectrum (Crow, 1990). This spectrum ranges 318 
from bipolar disorder without psychosis at one end and schizophrenia without 319 
affective symptoms at the other with patients with features of both disorders falling 320 
at some point in the middle (Craddock & Owen, 2005; Crow, 1990; Owen, 2014). 321 
Support for a dimensional approach comes from research showing overlap in the 322 
symptom profiles of these disorders (Keshavan et al., 2011), as well as evidence that 323 
the functional outcome of schizoaffective disorder is poorer than bipolar disorder 324 
but better than schizophrenia (Benabarre et al., 2001; Harrow, Grossman, Herbener, 325 
& Davies, 2000). Our finding that the degree of cognitive impairment increases from 326 
bipolar disorder to schizoaffective disorder to schizophrenia is consistent with this 327 
view. 328 
In our analyses of individual cognitive domains, participants with schizoaffective 329 
disorder were more impaired across all domains compared to participants with 330 
bipolar disorder. Effect sizes were smaller in comparisons between schizoaffective 331 
disorder and schizophrenia, but the most significant differences were observed for 332 
verbal learning (g=0.24) and speed of processing (g=0.18). Comparable effect sizes 333 
were reported in an earlier meta-analysis (Emre Bora et al., 2009), which found the 334 
schizophrenia group were more impaired than the schizoaffective disorder group on 335 
verbal memory (d=0.23), Wisconsin Card Sorting Test (d=0.21) and processing speed 336 
(d=0.24). This is an interesting finding as previous studies have shown that most of 337 
the impairments in specific domains seen in participants with schizophrenia can be 338 
accounted for by a general intelligence factor (‘g’) but ‘g’ does not fully account for 339 
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deficits in processing speed and verbal learning (Dickinson, Iannone, Wilk, & Gold, 340 
2004; Dickinson, Ragland, Gold, & Gur, 2008). This suggests that these abilities may 341 
be disproportionately affected in patients with schizophrenia and may differentiate 342 
them from participants with schizoaffective disorder. 343 
Few studies reported the proportion of subtypes of schizoaffective disorder in their 344 
sample. Therefore, it is difficult to draw any firm conclusions about differences in 345 
cognitive performance between the subtypes. In the subgroup analysis, no 346 
difference in cognitive performance was detected between participants with the 347 
depressive subtype and schizophrenia, although performance was marginally better 348 
in the schizoaffective disorder - depressive type group. A larger effect size was 349 
observed between the bipolar subtype and schizophrenia. Both subtypes were more 350 
impaired than bipolar disorder. These results suggest that the depressive subtype of 351 
schizoaffective disorder may have more severe cognitive impairments than those 352 
seen in the bipolar subtype and more closely resemble that of schizophrenia. Whilst 353 
there was some evidence of this in our comparison of the subtypes, this difference 354 
was not significant and should be interpreted with caution given that only two 355 
studies had data available. 356 
Limitations 357 
Several limitations of this meta-analysis should be noted. A small number of studies 358 
specified the subtypes of schizoaffective disorder and only two studies contained 359 
disaggregated data on both subtypes. Therefore, the results for the subtypes should 360 
be interpreted with caution. The studies included in this review employed different 361 
measures of cognition, which may explain the heterogeneity in the distribution of 362 
 20  
effect sizes for some domains. However, there was little evidence of heterogeneity 363 
in the analyses of composite cognition scores. There were also differences in the 364 
inclusion of stabilised and symptomatic participants across studies and few included 365 
a definition of remission. It has been argued that cognitive impairment may be 366 
affected by illness state at the time of assessment and studies of inpatients included 367 
in this meta-analysis reported no differences in cognitive performance between 368 
patient groups (Amann et al., 2012; K. E. Lewandowski, Cohen, Keshavan, & Öngür, 369 
2011; Szoke et al., 2008). Most studies included in this analysis recruited participants 370 
from outpatient clinics and therefore our results may not be generalizable to acutely 371 
unwell participants. 372 
This meta-analysis included studies from a wide range of countries and thus their 373 
methodologies differed on diagnostic criteria and cognitive assessments (both type 374 
and language). The use of different diagnostic criteria is particularly relevant in this 375 
meta-analysis, as criteria for schizoaffective disorder varies considerably between 376 
the Diagnostic and Statistical Manual (DSM), International Classification of Diseases 377 
(ICD) and Research Diagnostic Criteria (RDC). The majority of the studies (N=27) used 378 
DSM criteria so the diagnosis of schizoaffective disorder relied on mood symptoms 379 
being present for a substantial proportion of the total illness duration, with a period 380 
of at least two weeks of psychosis in the absence of mood. In contrast, ICD (utilised 381 
by one study) places an emphasis on first rank symptoms of schizophrenia for the 382 
diagnosis of schizoaffective disorder. Vollmer-Larsen et al. (Vollmer-Larsen, 383 
Jacobsen, Hemmingsen, & Parnas, 2006) demonstrated that using ICD-10 and DSM-384 
IV to diagnose schizoaffective disorder results in a different set of patients. Four 385 
studies defined schizoaffective disorder according to the RDC. Schizoaffective 386 
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disorder in RDC includes a broad range of patients including those with brief 387 
psychotic symptoms and chronic mood symptoms, and the converse (Spitzer, 388 
Endicott, & Robins, 1978). Thus, participants diagnosed with RDC schizoaffective 389 
disorder are a broad, heterogeneous group. The results of this meta-analysis are 390 
most generalizable to patients diagnosed according to the DSM and the results of 391 
studies using ICD or RDC may differ from those presented here. 392 
Conclusions 393 
Based on this review, we make several recommendations for future research. 394 
Studies should report the clinical characteristics of their sample, including patient 395 
status (with defined remission criteria), measures of mood, psychosis and negative 396 
symptoms, and classes and doses of psychiatric medication. The results of our 397 
analyses separating the subtypes of schizoaffective disorder have important 398 
implications for diagnostic classification and highlight the importance of considering 399 
heterogeneity within disorders. Studies that simply combine the subtypes of 400 
schizoaffective disorder may produce conflicting results and hamper efforts to 401 
understand the relationship between this disorder and schizophrenia or bipolar 402 
disorder. Given the heterogeneity of cognitive performance within diagnoses and 403 
the overlap in clinical features and underlying biology between disorders, a 404 
dimensional approach to measuring psychopathology (such as the National Institute 405 
for Mental Health’s Research Domain Criteria (T. Insel et al., 2010; T. R. Insel, 2014; 406 
Morris & Cuthbert, 2012)) may better inform investigations of the underlying 407 
aetiology of cognitive impairments in psychotic and mood disorders.408 
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Figure Legends 
Figure 1 PRISMA flowchart illustrating the methodological process of filtering 
potential studies 
The records excluded at the screening phase (n=250) included 25 reviews and meta-
analyses, 93 studies that compared schizophrenia and bipolar disorder but not 
schizoaffective disorder and 132 studies that did not fit the aims of this reviews. Full 
text articles were excluded due to combining diagnoses (n=10), children or 
adolescent participants (n=2), studies with unsuitable cognitive assessments (n=3), 
studies reported proportion of participants impaired or not impaired (n=2) or data 
was not available (n=1). 
Figure 2 Forest plot of individual and pooled random effect estimates of mean 
differences between schizophrenia and schizoaffective disorder 
Positive effect sizes indicate better performance in the schizoaffective disorder 
group. 
Figure 3 Forest plot of individual and pooled random effect estimates of mean 
differences between schizoaffective disorder and bipolar disorder 
Positive effect sizes indicate better performance in the schizoaffective disorder 
group. 
Figure 4 Cognitive performance across the bipolar-schizophrenia diagnostic 
spectrum 
 

















































































































Abbreviations: BACS, Brief Assessment of Cognition in Schizophrenia; BADS, Behavioural Assessment of the 
Dysexecutive Syndrome; BVMT-R, Brief Visuospatial Memory Test – Revised; BVRT, Benton Visual Retention Test; 
CANTAB, Cambridge Neuropsychological Test Automated Battery; CCST, California Card Sorting Test; CNTRICS, 
Cognitive Neuroscience Test Reliability and Clinical Applications for Schizophrenia; COWAT, Controlled Oral Word 
Association Test; CVLT, California Verbal Learning Test; D-KEFS, Delis-Kaplan Executive Function System; HVLT-R, 
Hopkins Verbal Learning Test – Revised; NAB: Neuropsychological Assessment Battery; RAVLT, Rey Auditory Verbal 
Learning Test; SCWT, Stroop Colour-Word Test; SDMT, Symbol Digits Modalities Test; TMT, Trail Making Test; VLMT, 
Verbal Learning & Retention Test; WAIS-III, Wechsler Adult Intelligence Scale - Third Edition; WAIS-R, Wechsler Adult 
Intelligence Scale – Revised Edition; WCST, Wisconsin Card Sorting Test; WM-MA, Working Memory – Mental 
Arithmetic Test; WMS-III, Wechsler Memory Scale – Third Edition; WMS-R, Wechsler Memory Scale – Revised Edition. 








SA vs. SZ SA vs. BD 
Amann et al. 1 26 SA (bipolar) 
45 SZ 








SA also met RDC 
WMS-III Verbal Memory 
WMS-III Working Memory 










Beatty et al. 2 11 SA  




CCST free sorting (perseverative 
sorts) 
0.26  





CVLT (trials 1-5) 
TMT A 
TMT B 






Bornstein et al. 4 18 SA 






WAIS-R Verbal IQ 
WAIS-R Performance IQ 
HRB Category Test (no of errors) 





HRB TPT Time 
HRB TPT Memory 
HRB TPT Location 
HRB Speech Perception 
HRB Seashore Rhythm 
HRB TMT A 


























SA vs. SZ 
SA vs. 
BD 
Bornstein et al. 4 
(cont.) 
18 SA 
55 SZ (28 paranoid, 
27 non-paranoid) 
52 HC 
 Primarily outpatients 
DSM-III-R 
HRB Finger Tap (right) 
HRB Finger Tap (left) 
HRB Grooved Peg (right) 
HRB Grooved Peg (left) 
HRB Finger Agnosia (right) 
HRB Finger Agnosia (left) 
HRB Graphesthesia (right) 










Chen et al. 5 50 SA (41 bipolar, 9 
depressive) 
48 SZ 





Stable patients from 





















DeRosse et al. 6 129 SA 
595 SZ (224 with 
mood, 371 without 
mood) 
269 BD (Type-I with 
psychosis) 
 Inpatients and 
outpatients 
DSM-IV 
WAIS-R Digit Span 
CVLT 
COWAT 















Evans et al. 7 24 SA (depressive 










Aphasia Screening Test 
WAIS-R Vocabulary 
Boston Naming Test 
WAIS-R Similarities 




Table S2 (cont.): Summary of studies included in meta-analysis 
Study Sample Sample Characteristics Neuropsychological Assessment 
Hedge’s g 
SA vs. SZ SA vs. BD 









WAIS-R Object Assembly 
WAIS-R Digit Symbol 
WAIS-R Block Design 
TPT 




   Abstraction / Cognitive Flexibility 






   Attention 
WAIS-R Digit Span 




   Learning and Incidental Memory 
CVLT (trials 1-5) 
Figure Memory Test (learning) 
Story Memory Test (learning) 
-0.38  
   Retention 
CVLT (long delay recall) 
Figure Memory Test (delayed) 




   Motor 
Finger Tapping Test 













SA vs. SZ 
SA vs. 
BD 




WCST (% conceptual level) 
WAIS-III Digit Symbol 
WAIS-III Digit Span 
WMS-R Logical Memory I 
HVLT-R 

















Glahn et al. 10 15 SA (depressive) 
15 SZ 
26 BD (11 with 
history of psychosis, 
15 without psychosis) 











WAIS-III Forward Digit Span 





Goldstein et al. 11 20 SA  
63 SZ (29 
undifferentiated, 20 










WAIS-R Information  





WAIS-R Picture Completion 
WAIS-R Picture Arrangement 

























SA vs. SZ SA vs. BD 
Goldstein et al. 11 
(cont.) 
20 SA  
63 SZ (29 
undifferentiated, 20 






WAIS-R Object Assembly 




Gooding & Tallent 
12 
23 SA (19 bipolar, 4 
depressive) 










WCST (perseverative errors) -0.18  





WAIS-III Vocabulary  
WAIS-III Matrix Reasoning  
WAIS-III Letter-Number 
WAIS-III Symbol Search  











Hill et al. 14 165 SA (55 depressive, 
110 bipolar) 
293 SZ 
227 BD (all with 








BACS Verbal Memory 
BACS Tower of London 
BACS Symbol Coding 
BACS Verbal Fluency 











Leposavic et al. 15 30 SA 























SA vs. SZ 
SA vs. 
BD 
Leposavic et al. 15 
(cont.) 
30 SA 









VITI Picture Completion 
VITI Picture Arrangement 
VITI Block Design 
VITI Object Assembly 





RCF (delayed recall) 
RAVLT (total words) 



















29 SA (all bipolar type) 
25 SZ 
31 BD (all with history 
of psychosis) 
20 HC 
 Stabilised inpatients 
and outpatients 
DSM-IV-TR 
TMT B 0.69 -0.07 
Lynham et al. 17 188 SA (76 bipolar, 112 
depressive) 
558 SZ 
78 BD (68 type I & 10 
type II / 59 with a history 
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SA vs. 
BD 
Lynham et al. 17 
(cont.) 
188 SA (76 bipolar, 
112 depressive) 
558 SZ 
78 BD (68 type I & 10 
type II / 59 with a 









WMS III: Spatial Span 
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LNNB Intellectual Processes 
LNNB Pathognomic 
LNNB Left Hemisphere 
















Miller et al. 19 26 SA (9 bipolar, 17 
depressive) 






























SA vs. SZ SA vs. BD 
Miller et al. 19 
(cont.) 
26 SA (9 bipolar, 17 
depressive) 















LNNB Intellectual Processes 
LNNB Pathognomic 
LNNB Left Hemisphere 
LNNB Right Hemisphere 
BVRT 
RAVLT (trials 1-5) 
WAIS-R Verbal IQ 















Mueser et al. 20 52 SA 
51 SZ 
36 BD 
 Outpatients aged 
50 or older 
DSM-IV 
Administered the DKEFS battery and 
derived factor scores (domains) using 



























CNTRICS: Dot Probe Expectancy -0.07  
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BACS Letter Fluency 
BACS Semantic Fluency 
BACS Symbol Coding 






Savage et al. 23 20 SA  




















Simonsen et al. 24 27 SA 
102 SZ 
136 BD (75 with 
history of 
psychosis & 61 
without / 80 





50/75 (67%) with 






WMS-III Logical Memory 
CVLT 
WAIS-III Digit Symbol 
WAIS-III Backward Digit Span 
WM-MA 2-back 
D-KEFS Phonetic Fluency 
D-KEFS Semantic Fluency 
D-KEFS Set Shifting 























CANTAB Motor Screening  
CANTAB Reaction Time 
CANTAB Stockings of Cambridge 


















SA vs. SZ SA vs. BD 




d2 Test (concentration) 
TMT A 
TMT B 
WAIS Forward Digit Span 
WAIS Backward Digit Span 
WAIS Forward Block Span 










Szoke et al. 27 25 SA 
48 SZ 
92 BD (52 with 
history of 
psychosis & 40 
without) 
48 HC 
 Inpatients (recruited 
prior to discharge) 
DSM-IV 
WCST 0.27 -0.65 










WAIS-R: Digit Symbol 
TMT A 
TMT B 
WMS-R: Forward Digit 
Span 
WMS-R: Backward Digit 
Span  
WMS-R: Forward Visual 
Span 


























SA vs. SZ SA vs. BD 
Torrent et al. 29 34 SA (bipolar) 
41 BD (16 Type – 









WAIS Forward Digit Span 

















Van Rheenen et al. 30 33 SA 
49 SZ 
35 BD (all Type-I; 







Processing Speed  
Digit Symbol Coding 
TMT A 
DKEFS Colour-Word 
Interference (word reading 
and colour naming) 
0.24 -0.20 
    Immediate Memory 
BVMT-R (trial 1) 
HVLT-R (trial 1) 
0.92 0.51 
    Learning 
BVMT-R (trials 1-3) 
HVLT-R (trials 1-3) 
0.24 -0.07 
    Semantic Memory 
Category Fluency: Animal 
Naming 
0.59 -0.67 
    Attention / Vigilance 
CPT-IP 
0.19 0.05 








SA vs. SZ 
SA vs. 
BD 













WMS: Spatial Span 
(backwards) 
0.01 -0.03 
 with psychosis, 9 
without) 
  Executive Function 
NAB Mazes 
DKEFS Colour-Word 
Interference (interference / 
switching blocks) 
0.18 0.26 












*Study not included in meta-analysis, as summary data and effect sizes were not reported. Note: Two authors responded to our requests for data. Eighteen studies not shown 
here were excluded due to combined diagnostic groups, ineligible cognitive assessments or for other reasons. Of these, there were 10 studies that combined diagnostic 
categories (e.g. schizophrenia and schizoaffective disorder as one, or schizoaffective disorder combined with other psychosis). The majority of these studies had very small 
samples of participants with schizoaffective disorder (N<20) and so we did not think it would be productive to request disaggregated data from these studies.  
Abbreviations:  BD, Bipolar Disorder; SA, Schizoaffective Disorder; SZ, Schizophrenia; BACS, Brief Assessment of Cognition in Schizophrenia; BADS, Behavioural 
Assessment of the Dysexecutive Syndrome; BVMT-R, Brief Visuospatial Memory Test - Revised; BVRT, Benton Visual Retention Test; CANTAB, Cambridge 
Neuropsychological Test Automated Battery; CCST, California Card Sorting Test; CNTRICS, Cognitive Neuroscience Test Reliability and Clinical Applications for 
Schizophrenia; COWAT, Controlled Oral Word Association Test; CPT-IP, Continuous Performance Test – Identical Pairs; CVLT, California Verbal Learning Test; D-KEFS, 
Delis-Kaplan Executive Function System; HRB, Halstead-Reitan Neuropsychological Battery; HVLT-R, Hopkins Verbal Learning Test – Revised; HVOT, Hooper Visual 
Organisation Test, LNNB, Luria-Nebraska Neuropsychological Battery; NAB, Neuropsychological Assessment Battery; RAVLT, Rey Auditory Verbal Learning Test; RCF, 
Rey Complex Figure Test; SCWT, Stroop Colour-Word Test; SDMT, Symbol Digits Modalities Test; TMT, Trail Making Test; TPT, Tactual Performance Test; VCAT, 
Verbal Concept Attainment Test; VITI, Wechsler’s Individual Test of Intelligence, Serbian translation of WAIS; VLMT, Verbal Learning & Retention Test; WAIS-III, 
Wechsler Adult Intelligence Scale - Third Edition; WAIS-R, Wechsler Adult Intelligence Scale – Revised Edition; WCST, Wisconsin Card Sorting Test; WM-MA, Working 
Memory – Mental Arithmetic Test; WMS-III, Wechsler Memory Scale – Third Edition; WMS-R, Wechsler Memory Scale – Revised Edition; WRAT, Wide Range 
Achievement Test.  
 
 
Table S3 Results of meta-regression analyses 
 
Schizophrenia & Schizoaffective 
Disorder 
Bipolar Disorder & Schizoaffective 
Disorder 
 N B 95% CIs p N B 95% CIs p 
Age 21 -0.06 -0.42 – 0.29 0.72 10 0.03 -0.45 – 0.5 0.92 
Age of Onset 10 0.21 -0.2 – 0.62 0.31     
Duration of 
Illness 
12 0.17 -0.27 – 0.6 0.45 7 -0.06 -0.51 – 0.4 0.81 
Years in 
Education 
14 0.1 -0.07 – 0.27 0.27     
Sex 17 0.02 -0.07 – 0.11 0.63 10 0.02 -0.16 – 0.19 0.84 
Psychosis 13 0.06 -0.21 – 0.33 0.65 5 -0.37 -1.2 – 0.46 0.38 
Depression 7 0.04 -0.69 – 0.77 0.91 6 -0.41 -0.97 – 0.15 0.15 
Negative 
Symptoms 
13 -0.08 -0.32 – 0.16 0.5 5 -0.27 -0.81 – 0.27 0.33 
Mania     7 -0.07 -0.45 – 0.31 0.72 
Current 
antipsychotics 
13 -0.06 -0.18 – 0.07 0.36 7 0.09 -0.06 – 0.24 0.25 
 
 


































































0.04 0.41 -0.44 
Positive effect sizes indicate better performance in the schizoaffective disorder group. 
 
 























































<1 x 10-4 0.56 0.82 
Positive effect sizes indicate better performance in the schizoaffective disorder group. 
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